The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma
Open accessAbstract
Background: Metabolic reprogramming and epigenetic alterations contribute to the aggressiveness of pancreatic ductal adenocarcinoma (PDAC). Lactate-dependent histone modification is a new type of histone mark, which links glycolysis metabolite to the epigenetic process of lactylation. However, the role of histone lactylation in PDAC remains unclear. Methods: The level of histone lactylation in PDAC was identified by western blot and immunohistochemistry, and its relationship with the overall survival was evaluated using a Kaplan-Meier survival plot. The participation of histone lactylation in the growth and progression of PDAC was confirmed through inhibition of histone lactylation by glycolysis inhibitors or lactate dehydrogenase A (LDHA) knockdown both in vitro and in vivo. The potential writers and erasers of histone lactylation in PDAC were identified by western blot and functional experiments. The potential target genes of H3K18 lactylation (H3K18la) were screened by CUT&Tag and RNA-seq analyses. The candidate target genes TTK protein kinase (TTK) and BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) were validated through ChIP-qPCR, RT-qPCR and western blot analyses. Next, the effects of these two genes in PDAC were confirmed by knockdown or overexpression. The interaction between TTK and LDHA was identified by Co-IP assay. Results: Histone lactylation, especially H3K18la level was elevated in PDAC, and the high level of H3K18la was associated with poor prognosis. The suppression of glycolytic activity by different kinds of inhibitors or LDHA knockdown contributed to the anti-tumor effects of PDAC in vitro and in vivo. E1A binding protein p300 (P300) and histone deacetylase 2 were the potential writer and eraser of histone lactylation in PDAC cells, respectively. H3K18la was enriched at the promoters and activated the transcription of mitotic checkpoint regulators TTK and BUB1B. Interestingly, TTK and BUB1B could elevate the expression of P300 which in turn increased glycolysis. Moreover, TTK phosphorylated LDHA at tyrosine 239 (Y239) and activated LDHA, and subsequently upregulated lactate and H3K18la levels. Conclusions: The glycolysis-H3K18la-TTK/BUB1B positive feedback loop exacerbates dysfunction in PDAC. These findings delivered a new exploration and significant inter-relationship between lactate metabolic reprogramming and epigenetic regulation, which might pave the way toward novel lactylation treatment strategies in PDAC therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012 · cited 2×
“Histones are involved in regulating various physiological functions, and post-translational modifications of histones (such as acetylation, succinylation) play important roles in the development of diseases [12].”
BackgroundMetabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418 · cited 1×
“Reprogramming cellular metabolism to support proliferation and various cellular processes is considered a key hallmark of cancer [27].”
BackgroundLactate Metabolism in Human Lung Tumors
Faubert, B., Li, K. Y., Cai, L., Hensley, C. T., Kim, J., Zacharias, L. G., Yang, C., Do, Q. N., Doucette, S., Burguete, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.019 · Cited by 1,343
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Yu, J., Chai, P., Xie, M., Ge, S., Ruan, J., Fan, X., & Jia, R. (2021) · Genome Biology · doi:10.1186/s13059-021-02308-z · Cited by 940
Pan, R.-Y., He, L., Zhang, J., Liu, X., Liao, Y., Gao, J., Liao, Y., Yan, Y., Li, Q., Zhou, X., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.013 · Cited by 862
Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
Moreno-Yruela, C., Zhang, D., Wei, W., Bæk, M., Liu, W., Gao, J., Danková, D., Nielsen, A. L., Bolding, J. E., Yang, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abi6696 · Cited by 841
Yang, K., Fan, M., Wang, X., Xu, J., Wang, Y., Tu, F., Gill, P. S., Ha, T., Liu, L., Williams, D. L., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-021-00841-9 · Cited by 798
The molecular biology of spindle assembly checkpoint signaling dynamics.
Musacchio, A. (2015) · Current Biology · doi:10.1016/j.cub.2015.08.051 · Cited by 778 · cited 1×
“Considering TTK’s dual specificity kinase activity towards both tyrosine and serine/threonine residues [26], we were interested in determining whether TTK has the capability to phosphorylate LDHA.”
BackgroundMetabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Intracellular Crotonyl-CoA Stimulates Transcription through p300-Catalyzed Histone Crotonylation
Sabari, B. R., Tang, Z., Huang, H., Yong-Gonzalez, V., Molina, H., Kong, H. E., Dai, L., Shimada, M., Cross, J. R., Zhao, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.029 · Cited by 659
Yang, Z., Yan, C., Ma, J., Peng, P., Ren, X., Cai, S., Shen, X., Wu, Y., Zhang, S., Wang, X., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-022-00710-w · Cited by 589
Histone Lactylation Boosts Reparative Gene Activation Post–Myocardial Infarction
Wang, N., Wang, W., Wang, X., Mang, G., Chen, J., Yan, X., Tong, Z., Yang, Q., Wang, M., Chen, L., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.320488 · Cited by 572
Targeting Mitosis in Cancer: Emerging Strategies
Dominguez-Brauer, C., Thu, K. L., Mason, J. M., Blaser, H., Bray, M. R., & Mak, T. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.11.006 · Cited by 495
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Grossberg, A. J., Chu, L. C., Deig, C. R., Fishman, E. K., Hwang, W. L., Maitra, A., Marks, D. L., Mehta, A., Nabavizadeh, N., Simeone, D. M., et al. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21626 · Cited by 489
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Zhang, D., Li, J., Wang, F., Hu, J., Wang, S., & Sun, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.003 · Cited by 462
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin, C., Yang, G., Yang, J., Ren, B., Wang, H., Chen, G., Zhao, F., You, L., Wang, W., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01169-7 · Cited by 413
Self-citationDaemen, A., Peterson, D., Sahu, N., McCord, R., Du, X., Liu, B., Kowanetz, K., Hong, R., Moffat, J., Gao, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501605112 · Cited by 398
Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation
Mao, Y., Zhang, J., Zhou, Q., He, X., Zheng, Z., Wei, Y., Zhou, K., Lin, Y., Yu, H., Zhang, H., et al. (2024) · Cell Research · doi:10.1038/s41422-023-00864-6 · Cited by 359
The enhancement of glycolysis regulates pancreatic cancer metastasis
Yang, J., Ren, B., Yang, G., Wang, H., Chen, G., You, L., Zhang, T., & Zhao, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03278-z · Cited by 347
Self-citationItoh, Y., Esaki, T., Shimoji, K., Cook, M., Law, M. J., Kaufman, E., & Sokoloff, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831078100 · Cited by 297
Zhang, N., Zhang, Y., Xu, J., Wang, P., Wu, B., Lu, S., Lu, X., You, S., Huang, X., Li, M., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00844-w · Cited by 292
Jiang, S.-H., Li, J., Dong, F.-Y., Yang, J.-Y., Liu, D.-J., Yang, X.-M., Wang, Y.-H., Yang, M.-W., Fu, X.-L., Zhang, X.-X., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.008 · Cited by 288
Self-citationChen, Q., Yang, B., Liu, X., Zhang, X. D., Zhang, L., & Liu, T. (2022) · Theranostics · doi:10.7150/thno.73223 · Cited by 261
Yang, J., Luo, L., Zhao, C., Li, X., Wang, Z., Zeng, Z., Yang, X., Zheng, X., Jie, H., Kang, L., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73398 · Cited by 240
Self-citationThe regulatory enzymes and protein substrates for the lysine β-hydroxybutyrylation pathway
Huang, H., Zhang, D., Weng, Y., Delaney, K., Tang, Z., Yan, C., Qi, S., Peng, C., Cole, P. A., Roeder, R. G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe2771 · Cited by 230
Xie, B., Lin, J., Chen, X., Zhou, X., Zhang, Y., Fan, M., Xiang, J., He, N., Hu, Z., & Wang, F. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01856-1 · Cited by 216
Histone lactylation: epigenetic mark of glycolytic switch
Dai, X., Lv, X., Thompson, E. W., & Ostrikov, K. (. (2022) · Trends in Genetics · doi:10.1016/j.tig.2021.09.009 · Cited by 203
Grützmann, R., Pilarsky, C., Ammerpohl, O., Luttges, J., Böhme, A., Sipos, B., Foerder, M., Alldinger, I., Jahnke, B., Schackert, H. K., et al. (2004) · Neoplasia · doi:10.1593/neo.04295 · Cited by 198
Moonlighting functions of metabolic enzymes and metabolites in cancer
Pan, C., Li, B., & Simon, M. C. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.031 · Cited by 193
Zhao, Z., Han, F., Yang, S., Wu, J., & Zhan, W. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.046 · Cited by 181
Histone Lactylation: A New Role for Glucose Metabolism
Liberti, M. V., & Locasale, J. W. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.12.004 · Cited by 169
Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers
Comandatore, A., Frańczak, M., Smolenski, R. T., Morelli, L., Peters, G. J., & Giovannetti, E. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.001 · Cited by 158
Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors
Kes, M. M. G., den Bossche, J. V., Griffioen, A. W., & Huijbers, E. J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188427 · Cited by 152
Liu, M., Quek, L., Sultani, G., & Turner, N. A. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0160-x · Cited by 109
Dong, S., Huang, F., Zhang, H., & Chen, Q. (2019) · Bioscience Reports · doi:10.1042/bsr20182306 · Cited by 109
Targeting lactate-related cell cycle activities for cancer therapy
Lin, J. L., Liu, G., Chen, L., Kwok, H. F., & Lin, Y. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.009 · Cited by 101
Cao, L., Wu, J., Qu, X., Sheng, J., Cui, M., Liu, S., Huang, X., Xiang, Y., Li, B., Zhang, X., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01765-x · Cited by 98
Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells
Kaistha, B. P., Honstein, T., Müller, V., Bielak, S., Sauer, M., Kreider, R., Fassan, M., Scarpa, A., Schmees, C., Volkmer, H., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.460 · Cited by 95
Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
Dreyer, S. B., Upstill‐Goddard, R., Legrini, A., Biankin, A. V., Allison, S. J., Biankin, A. V., Beraldi, D., Cameron, E. J., Chang, D. K., Cooke, S. L., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.09.022 · Cited by 54
LKB1 controls inflammatory potential through CRTC2-dependent histone acetylation
Compton, S. E., Kitchen-Goosen, S. M., DeCamp, L. M., Lau, K. H., Mabvakure, B. M., Vos, M., Williams, K. S., Wong, K., Shi, X., Rothbart, S. B., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.04.017 · Cited by 52
Zhao, Y., Li, S., Chen, Y., Wang, Y., Wei, Y., Zhou, T., Zhang, Y., Yang, Y., Chen, L., Liu, Y., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.02.007 · Cited by 45
Xue, W., Li, X., Li, W., Wang, Y., Jiang, C., Zhou, L., Gao, J., Yu, Y., Shen, Y., & Xu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00856-1 · Cited by 39
Li, S., Gao, J., Zhuang, X., Zhao, C., Hou, X., Xing, X., Chen, C., Liu, Q., Liu, S., & Luo, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30297 · Cited by 37
Zhou, X., Yuan, Y., Kuang, H., Bingxiang, T., Zhang, H., & Zhang, M. (2022) · Bioengineered · doi:10.1080/21655979.2021.2013108 · Cited by 35
Li, J., Zhang, Q., Guan, Y., Liao, D., Jiang, D., Xiong, H., Zhan, H., & Pang, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04863-0 · Cited by 35
Kaoutari, A. E., Fraunhoffer, N. A., Audebert, S., Camoin, L., Berthois, Y., Gayet, O., Roques, J., Bigonnet, M., Bongrain, C., Ciccolini, J., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104634 · Cited by 11
Cited by
Epigenetics-targeted drugs: current paradigms and future challenges
Dai, W., Qiao, X., Fang, Y., Guo, R., Bai, P., Liu, S., Li, T., Jiang, Y., Wei, S., Na, Z., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02039-0 · Cited by 339
Lactate: A key regulator of the immune response
Llibre, A., Kucuk, S., Gope, A., Certo, M., & Mauro, C. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.008 · Cited by 283
Metadata
- Authors
- Li, F., Si, W., Xia, L., Yin, D., Wei, T., Tao, M., Cui, X., Yang, J., Hong, T., & Wei, R.
- Venue
- Molecular Cancer
- Published
- 2024-05-06
- Volume
- 23
- Issue
- 1
- Pages
- 90-90
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W4396661350
- Cited by
- 390
- References
- 50
- FWCI
- 59.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.